21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Pharmaceutical kit comprising anti-human seminal plasma protein single chain antibody/human carboxypeptidase fusion protein and prodrug
#25502Composition and method for treatment of wounds
#25503Therapeutic biological product and method for formation of new vascularised bone
#25504Composition for topical treatment
#25505Composition for promoting hair growth
#25506Use of a composition containing extracts of Vitis vinifera and lycopersicum for protecting the skin
#25507Sleep inducing toothpaste made with natural herbs and a natural hormone
#25508Appetite control compositions and methods of use
#25509Combined doses of formoterol and fluticasone
#25510Use of collagenase to facilitate guide wire crossing in total arterial occlusions
#25511Anti-pathogenic composition useful in blood preservation
#25512Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
#25513Process for preparing water soluble diterpenes and their applications
#25514Use of L-carnitine in the prevention and treatment of hearing loss
#25515Production of Δ 9 tetrahydrocannabinol
#25516Use of cholinesterase antagonists to treat insulin resistance
#25517Therapeutic combinations
#25518Pharmaceutical composition comprising an AChE inhibitor and a mGluR2 antagonist
#25519Method for treating erectile dysfunction and increasing libido in men
#25520Therapeutic applications of 2-hydroxyacetanilide
#25521Use of bisphosphonates for otosclerosis
#25522Antimicrobial mixtures comprising iodopropynyl compounds and dimethyldithiocarbamate derivatives
#25523Dosing regimen for Flaviviridae therapy
#25524Methods and compositions for nerve regeneration
#25525Compositions comprising thylakoids useful in the modulation of inflammation process
#25526Therapeutic composition providing enhanced cardiac function
#25527Antioxidant compositions and methods thereto
#25528Topical compositions having a natural ingredient and method of use
#25529Rehydrating beverage with Rhodiola crenulata and D-ribose that enhances blood oxygen and relieves post-exertional muscle cramping and soreness
#25530Therapeutic composition providing respiratory relief
#25531Methods and compositions to aid breast enhancement
#25532Process for producing collagen production enhancers and use thereof
#25533Glycoprotein matrix compositions and methods related thereto
#25534Antimicrobial composition for medical articles
#25535Dosage form comprising self-destructive membrane
#25536Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
#25537Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
#25538Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
#25539Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
#25540Prevention and treatment of amyloidogenic disease
#25541Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
#25542Methods of using adipose derived stem cells to promote wound healing
#25543Defective recombinant adenoviruses expressing cytokines for antitumor treatment
#25544Medical device with coating that promotes endothelial cell adherence
#25545Methods of improving the safety of zonisamide therapy
#25546Methods of using zonisamide as an adjunctive therapy for partial seizures
#25547Methods of using zonisamide as an adjunctive therapy for partial seizures
#25548Active ingredient for producing a substance containing isocitrate for influencing the coagulation tendency of blood
#25549Remedies for glaucoma comprising bunazosin and prostaglandins
#25550Combinations comprising a selective cyclooxygenase-2 inhibitor
#25551Pharmaceutical composition for the prevention and treatment of addiction in a mammal
#25552Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
#25553Oral composition to reduce cold symptoms and duration of same
#25554Dimeric compounds and their use as anti-viral agents
#25555Use of chromen-4-one derivatives
#25556Combination therapy comprising zd6474 and a taxane
#25557Pharmaceutically active uridine esters
#25558Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
#25559Combined agents for treatment of glaucoma
#25560Synthesis of epothilones, intermediates thereto, analogues and uses thereof
#25561Bactericidal antimicrobial methods and compositions for use in treating gram positive infections
#25562Methods to mobilize progenitor/stem cells
#25563Pyridylpyrrole derivatives active as kinase inhibitors
#25564Pharmaceutical composition for the prevention and treatment of addiction in a mammal
#25565Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
#25566Pharmaceutical composition for the prevention and treatment of addiction in a mammal
#25567Pyrimidylpyrrole derivatives active as kinase inhibitors
#25568Method for treating atopic disorders
#25569Formulations for reducing neuronal degeneration
#25570Composition comprising L-arginine as a muscle growth stimulant and use thereof
#25571Pharmaceutical compositions and methods for lowering blood pressure and pulse rate
#25572Heparin-containing ophthalmic agent
#25573Pharmaceutically active uridine esters
#25574Methods of treating xerostomia and xerophthalmia
#25575Method of treatment of otitis externa
#25576Methods of reducing visceral fat by increasing levels of insulin-like growth factor-I (IGF-I)
#25577Exendins and exendin agonists for weight reduction and obesity
#25578Use of VEGF-C or VEGF-D in reconstructive surgery
#25579Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
#25580Therapy for growth hormone induced insulin resistance in juveniles with growth disorders
#25581Use of long pentraxin ptx3 for the treatment of fgf-8 mediated tumour diseases
#25582GLP-1 formulations with protracted time action
#25583Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
#25584Inhibitor of stem cell proliferation and uses thereof
#25585Stabilized compositions containing an oxygen-labile active agent and lactoglobulin
#25586Antiglaucomatous agent and use thereof
#25587Differential inhibition of p38 map kinase isoforms
#25588Diagnosis and management of infection caused by chlamydia
#25589Antiradicals and fat compositions, foods, drinks, drugs or feeds containing the antiradicals
#25590Method of producing an oil extract from seeds of plants via a binary azeotropic solvent mixture
#25591Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
#25592Plant extracts for the treatment of increased bone resorption
#25593Solubility and Absorption Promoter
#25594Stabilized compositions containing an oxygen-labile active agent and a plant extract
#25595Pharmaceutical composition having cholagogic and litholytic effect and its preparation method
#25596Stabilized compositions containing an oxygen-labile active agent
#25597Novel substituted benzimidazole dosage forms and method of using same
#25598Therapeutic protocols
#25599Anti-angiogenic compositions and methods of use
#25600Histamine and CCK2/gastrin receptor blockade in the treatment of acid-peptic disease and cancer
#25601Transdermal delivery system for alkaloids of aconitum species
#25602Pharmaceutical composition and method for transdermal drug delivery
#25603Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase the intramyocellular lipid level
#25604Regulation of biodegradability of composite biomaterials
#25605Warming and nonirritating lubricant compositions and method of comparing irritation
#25606Warming and nonirritating lubricant compositions and method of comparing irritation
#25607Dr. Bob's Arthritis Cream
#25608Plant extract active as an immunostimulating agent
#25609Stabilized compositions containing an oxygen-labile active agent and a fungal extract
#25610Method and pharmaceutical composition for the treatment of immune disorders
#25611Methods and products related to metabolic interactions in disease
#25612Monoclonal antibodies against interleukin-22
#25613Engineered Fab' fragment anti-tumor necrosis factor alpha in combination with disease modifying anti-rheumatic drugs
#25614Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound
#25615Body tissue filling material, production method thereof and body tissue filler
#25616Compositions for and methods of treating and preventing sirs/sepsis
#25617Histidine-rich glycoprotein
#25618Method for rendering a contact lens wettable
#25619All natural sunscreen lotion
#25620Topical compositions of urea
#25621Medicaments for inhalation comprising a novel anticholinergic and a steroid
#25622Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma
#25623Method and device for generating mists and medical uses thereof
#25624Methods for producing sterol ester-rich compositions
#25625Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#25626Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
#25627Phenyl naphthol ligands for thyroid hormone receptor
#25628Novel class of compounds (Choline derivatives, esp. Stearyl Choline Cloride and other salts) for the treatment of Alzheimer's disease, Down syndrome and central (and/or peripheral) nervous system and memory related disorders or for enhancements
#25629Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease
#25630Upregulation of type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
#25631Combination of phenylcarboxamides with blockers of the IKr channel and their use for the treatment of atrial arrhythmias
#25632Method of treating acute pain with unitary dosage form comprising ibuprofen and oxycodone
#25633Methods and materials for the treatment of pain comprising opioid antagonists
#25634Synergistic enhancement of cognitive ability
#25635Use of propionyl-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
#25636Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
#25637Hydroxy substituted amides for the treatment of alzheimer's disease
#25638Meloxicam compositions
#25639Method and composition for restoring diuretic and renal function
#25640Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
#25641Dosage forms of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
#25642Triphasic oral contraceptive
#25643Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
#25644Transdiscal administration of cycline compounds
#25645Enhancement of magnesium uptake in mammals
#25646Bulking agents as satiety agents
#25647Composition and method for treating neurological disorders
#25648Compositions and methods for the treatment of depression and other affective disorders
#25649Smooth muscle cell differentiation with CRP, SRF and GATA factors
#25650Method and compositions for producing berry derived products
#25651Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
#25652Compositions enriched in anthocyanins
#25653Composition for heart disease, its active ingredients, method to prepare same and uses thereof
#25654Vascularization therapy by highly concentrated carbonated warm water bath
#25655Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agent
#25656Method for promoting bone growth
#25657Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them
#25658Formulation and manufacturing process for Coenzyme Q10 soft gel capsules
#25659NUTRITIONAL FORMULATIONS
#25660Emulsifying systems containing azetidine derivatives
#25661Topical compositions of urea and ammonium lactate
#25662Composition for treatment of tinea pedis and method of use
#25663Prevention and treatment of amyloidogenic disease
#25664Methods and compositions comprising kava and mate' or theobromine
#25665HCV combination therapy
#25666Methods of inhibiting TNFα in patients with cancer
#25667Methods for treating conditions associated with the accumulation of excess extracellular matrix
#25668Formulation and manufacturing process for Coenzyme Q10 soft gel capsules
#25669Genetic vaccines for cancer therapy
#25670Compounds and methods for downregulating the effects of TGF-beta
#25671Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
#25672USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY
#25673Compositions and methods for treating skin conditions
#25674Topical compositions of ammonium lactate
#25675Compositions and methods for the treatment of aches and pains
#25676Drug/drug delivery systems for the prevention and treatment of vascular disease
#25677Synthesis of epothilones, intermediates thereto, analogues and uses thereof
#25678Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
#25679ANTI-T CELL IMMUNOTOXIN FUSION PROTEIN AND ITS THERAPEUTIC USE
#25680Lutein/zeaxanthin for glare protection
#25681Composition and use of allylamine derivatives
#25682Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination
#25683Medicament for the treatment of viral skin and tumour diseases
#25684Biodegradable penetration enhancers with multiple hydrophilic moieties
#25685Compositions, kits, and methods for treating gastrointestinal conditions
#25686Aniline-derived ligands for the thyroid receptor
#25687Botanical extract compositions and methods of use
#25688Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
#25689Oral pharmaceutical composition containing a combination pparalpha and a hmg-coa reductase inhibitor
#25690Pharmaceutical compositions comprising sumatriptan and metoclopramide, and methods of use thereof
#25691Therapeutic compositions and methods of treating glycolipid storage related disorders
#25692Novel therapeutic use of a thienylcyclohexylamine derivative
#25693Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
#25694Compositions containing a ruthenium(III) complex and a heterocycle
#25695Combination drug therapy for treating hypertension
#25696Use of CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients
#25697Method of treating functional bowel disorders
#25698Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
#25699Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
#25700Lipid profile modulation
#25701Antitumor combined therapy
#25702Hormone replacement therapy and depression
#25703Nutritional supplements
#25704Multistage preparation for contraception based on natural estrogens
#25705Substituted phenol compounds useful for anesthesia and sedation
#25706Methods for treatment of dermatological conditions
#25707Compositions and method for steroid homeostasis
#25708Vitamin Compositions
#25709Vitamin compositions for the treatment and prevention of vascular disease and dementia
#25710Method of treating cancer by conjunctive therapy with 2'-haloemethylidene derivatives and a S-phase or M-phase specific antineoplastic agent
#25711Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
#25712Methods of administering dalbavancin for treatment of skin and soft tissue infections
#25713Anthelmintic formulations
#25714Anthelmintic formulations
#25715Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds
#25716Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
#25717Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents
#25718Method of preparation of stabilized thrombin-activatable fibrinolysis inhibitor (TAFI) and methods of use thereof
#25719Method of treating cancer with a VEGF antagonist and an anti-proliferative agent
#25720Stabilized formulation of parathyroid hormone
#25721Methods for treating glaucoma
#25722Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia
#25723Remedies for bone loss
#25724SAIF, an anti-inflammatory factor, and methods of use thereof
#25725Antioxidative compositions
#25726Sea Buckthorn compositions and associated methods
#25727Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
#25728Agent for suppressing or preventing gastralgia, and composition for food or beverage
#25729Method for processing ginseng and the uses of extract of processed ginseng
#25730Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity or pain
#25731Composition comprising a zeolite compound for treatment of diseases
#25732Viscosity-stable compositions useful for treating gastrointestinal disorders
#25733Tricalcium phosphates, their composites, implants incorporating them, and method for their production
#25734Methods for promoting growth of bone, ligament, and cartilage using zvegf4
#25735Spray drying processes for forming solid amorphous dispersions of drugs and polymers
#25736Pharmaceutical composition for controlled release of a beta-lactam antibiotic
#25737Formulation and manufacturing process for Coenzyme Q10 soft gel capsules
#25738Prevention and treatment of amyloidogenic disease
#25739Combined cancer treatment methods using selected antibodies to aminophospholipids
#25740Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis
#25741Lyase treatment for
#25742Compositions and methods of treating diabetes
#25743Composition comprising a strain and uses thereof
#25744Pharmaceutical composition for treatment of cancers
#25745Tumor-specific promotor and use thereof
#25746Method of treating hepatitis C infection
#257472′-branched nucleosides and Flaviviridae mutation
#25748Immune response induction method
#25749Method for treating hepatitis c virus infection in treatment failure patients
#25750Method for treating hepatitis c virus infection in treatment failure patients
#25751Oral administration of beta-carotene, lycopene and lutein for human skin protection
#25752Acellular tissue matrices made from alpa-1,3-galactose-deficient tissue
#25753Aqueous 2,6-diisopropylphenol pharmaceutical compositions
#25754Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner
#25755Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
#25756Methods of therapeutic treatment using retinoids with reduced side effects
#25757Methods and compounds useful to induce apoptosis in cancer cells
#25758Taxane prodrugs
#25759Treatment and prevention of cardiovascular events
#25760Use of central cannabinoid receptor antagonists for the preparation of drugs
#25761Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient
#25762Methods for treating inflammation and inflammation-associated diseases with a statin and ether
#25763Zonisamide use in eating disorders
#25764Analgesic and anti-inflammatory compositions comprising domperidone and methods of using the same
#25765Methods of treating nodulocystic acne
#25766Methods of therapeutic treatment using retinoids with reduced drug interaction
#25767Medicaments for inhalation comprising an anticholinergic and a betamimetic
#25768Compositions containing alpha-2-adrenergic agonist components
#25769Method of treating lower urinary tract disorders
#25770Semi-solid systems containing azetidine derivatives
#25771Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
#25772Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy
#25773Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
#25774Medicaments for inhalation comprising an anticholinergic and a steroid
#25775Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
#25776Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
#25777Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
#25778Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
#25779Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
#25780Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
#25781Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
#25782Use of bisphosphonates for the treatment of osteogenesis imperfecta
#25783Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
#25784Agents and methods for treatment of disease by oligosaccharide targeting agents
#25785Method of augmenting the antitumor activity of anticancer agents
#25786Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
#25787Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
#25788Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
#25789Methods for treating, preventing, or inhibiting injuries, cell membrane stabilization, and calcium mobilization using pseudopterosin compounds
#25790Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
#25791Compositions of Alpha3beta4 Receptor antagonists and opioid agonist analgesics
#25792Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators
#25793Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
#25794Recombinant human alpha-fetoprotein as an immunosuppressive agent
#25795PSCA antibodies and hybridomas producing them
#25796Microbicidal compositions and method of use
#25797Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
#25798Standardized extracts of
#25799Herbal pharmaceutical composition for treatment of cardiovascular disease
#25800Therapeutic methods using herbal compositions